FDA Approved: POLIVY — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA's original approval of POLIVY (polatuzumab vedotin) by Genentech for adults with relapsed or refractory diffuse large B-cell lymphoma in combination with be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Polivy (polatuzumab vedotin)

Snippet

ORIG AP for POLIVY (POLATUZUMAB VEDOTIN)